Mankind Pharma Ltd.

View in App
1925.05 +27.45 ▲1.5%

01 December 2023, 11:36:59 AM
Volume: 78,818

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.mankindpharma.com
Market Cap 77,121.29 Cr.
Enterprise Value(EV) 75,079.60 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 32.00 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 60.16 Trailing Twelve Months Ending 2023-03
Industry PE 38.68 Trailing Twelve Months Ending 2023-03
Book Value / Share 210.40 Trailing Twelve Months Ending 2023-03
Price to Book Value 9.15 Calculated using Price: 1,925.20
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 40.06 Cr. 400,588,440 Shares
FaceValue 1
About Mankind Pharma Ltd.
The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Mankind Pharma Ltd. Performance

View details >>
1 Day
+1.45%
1 Week
-0.46%
1 Month
+9.83%
3 Month
+8.15%
6 Month
+41.97%
1 Year
2 Year
5 Year
10 Year

Mankind Pharma Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 21.61 25.06 24.28 23.69 21.06 33.12 31.51 26.72 19.27
Return on Capital Employed (%) 30.32 36.47 35.49 33.47 28.49 43.22 39.97 33.96 23.49
Return on Assets (%) 17.54 20.08 19.10 16.98 14.22 22.94 22.79 18.83 13.94

Mankind Pharma Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2,055 2,257 2,927 2,881 2,823 3,485 4,722 6,155 7,435 8,428
Non Curr. Liab. 28 34 53 49 78 103 107 169 199 236
Curr. Liab. 433 528 663 1,296 1,024 1,251 1,353 2,623 1,863 2,128
Minority Int. 16 29 98 134 159 186 141 161 188 205
Equity & Liab. 2,532 2,848 3,741 4,360 4,084 5,025 6,324 9,108 9,686 10,998
Non Curr. Assets 859 1,142 1,672 1,787 2,085 2,206 2,417 4,702 5,358 5,335
Curr. Assets 1,673 1,707 2,069 2,574 1,998 2,820 3,907 4,404 4,325 5,662
Misc. Exp. not W/O
Total Assets 2,532 2,848 3,741 4,360 4,084 5,025 6,324 9,108 9,686 10,998

Mankind Pharma Ltd. Profit and Loss

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 3,323 3,944 4,382 4,949 4,980 5,872 6,214 7,782 8,749
Other Income 76 71 108 72 53 104 171 196 129
Total Income 3,399 4,015 4,490 5,021 5,033 5,976 6,385 7,978 8,878
Total Expenditure -2,738 -3,185 -3,536 -3,933 -4,055 -4,427 -4,565 -5,791 -6,848
PBIDT 662 830 953 1,088 978 1,549 1,820 2,187 2,031
Interest -2 -3 -4 -25 -44 -23 -21 -60 -46
Depreciation -39 -43 -31 -46 -69 -99 -119 -167 -326
Taxation -177 -244 -290 -329 -264 -382 -399 -522 -362
Exceptional Items
PAT 444 540 629 688 601 1,045 1,293 1,453 1,310
Minority Interest -6 -28 -32 -26 -28 -19 -28
Share Associate 1 2 0 -3 10 12
Other Related Items
Consolidated Net Profit 439 542 629 656 579 1,030 1,265 1,433 1,282
Adjusted EPS 11 14 16 16 14 26 32 36 32

Mankind Pharma Ltd. Cash Flow

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 280 537 628 639 600 1,072 1,137 920 1,813
Cash Fr. Inv. -348 -152 -625 -505 -444 -439 -1,222 -1,369 -1,054
Cash Fr. Finan. 9 -361 2 -89 -175 -527 -8 605 -740
Net Change -59 25 5 46 -19 106 -93 155 19
Cash & Cash Eqvt 39 78 87 135 116 226 127 283 305

Mankind Pharma Ltd. Shareholding Pattern

View details >>
3 Qtrs 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 76.50 76.50 76.50
Public 23.50 23.50 23.50
Depository Receipts 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00

Mankind Pharma Ltd. Announcements

View details >>
Thu, 30 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Mankind Pharma Limited has informed the Exchange about Schedule of meet
Tue, 28 Nov 2023
Updates
Mankind Pharma Limited has informed the Exchange regarding 'submission of application for reclassification from Promoter & Promoter Group Category to Public Category under Regulation 31A(8) of the Securities & Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015'.
Wed, 22 Nov 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Intimation of participation in Investor Conference - Update

Mankind Pharma Ltd. Technical Scans

View details >>
Thu, 30 Nov 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone

Mankind Pharma Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 294,434.39 1,229.55 +0.3%
Divi's Laboratories Ltd. 100,534.28 3,802.90 +0.4%
Cipla Ltd. 97,810.50 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. 96,539.80 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. 79,515.07 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. 71,999.19 2,133.85 +0.3%
Zydus Lifesciences Ltd. 64,563.44 642.65 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.44 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 75.49 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-09 28.32 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.96 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.00 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.97 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-09 23.00 642.65 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.92 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.93 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-09 3.94 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.79 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.23 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.73 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-09 3.45 642.65 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 642.65 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 642.65 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 642.65 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 642.65 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,229.55 +0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,802.90 +0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,209.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,803.50 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,577.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,133.85 +0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 642.65 +0.8%

Mankind Pharma Ltd. FAQ's

What is Mankind Pharma share price?
Can I buy Mankind Pharma shares now?
What is the Market Cap of Mankind Pharma?
What are the key metrics to analyse Mankind Pharma?
What is the 52 Week High and Low of Mankind Pharma?
What is the trend of Mankind Pharma share price?